At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 405 enrolled
Drug / intervention
Placebo +2 moredrug
Likely dose
Acurox 5/30 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, Repeat-dose Study of the Safety and Efficacy of Acuroc Tablets Following Bunionectomy Surgery in Adult Patients
In Brief
A Phase 3 clinical trial evaluating Placebo, Acurox 5/30 mg, and 1 other intervention for Pain. Completed, enrolled 405 participants.
Detailed Summary
The purpose of this study is to determine whether oxycodone HCl and niacin are effective in the treatment of pain following bunionectomy surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2007
Primary CompletionFeb 2008
Study CompletionMar 2008
First PostedApr 2008
TodayJul 2026
First PostedApr 7, 2008
Enrollment StartSep 1, 2007
Primary CompletionFeb 1, 2008
Study CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 18.2 years ago
Interventions
Placebodrug
2 tablets every 6 hours for 48 hours
Acurox 5/30 mgdrug
2 tablets every 6 hours for 48 hours
Acurox 7.5/30drug
2 tablets every 6 hours for 48 hours